Treatment of heart failure in Dutch general practice
- PMID: 16822303
- PMCID: PMC1533835
- DOI: 10.1186/1471-2296-7-40
Treatment of heart failure in Dutch general practice
Abstract
Background: To study the relation between the prescription rates of selected cardiovascular drugs (ACE-inhibitors and Angiotensin receptor blockers, beta-blockers, diuretics, and combinations), sociodemographic factors (age, gender and socioeconomic class) and concomitant diseases (hypertension, coronary heart disease, cerebrovascular accident, heart valve disease, atrial fibrillation, diabetes mellitus and asthma/COPD) among patients with heart failure cared for in general practice.
Methods: Data from the second Dutch National Survey in General Practice, conducted mainly in 2001. In this study the data of 96 practices with a registered patient population of 374.000 were used. Data included diagnosis made during one year by general practitioners, derived from the electronic medical records, prescriptions for medication and sociodemographic characteristics collected via a postal questionnary (response 76%)
Results: A diagnosis of HF was found with 2771 patients (7.1 in 1000). Their mean age was 77.7 years, 68% was 75 years or older, 55% of the patients were women. Overall prescription rates for RAAS-I, beta-blockers and diuretics were 50%, 32%, 86%, respectively, whereas a combination of these three drugs was prescribed in 18%. Variations in prescription rates were mainly related to age and concomitant diseases.
Conclusion: Prescription is not influenced by gender, to a small degree influenced by socioeconomic status and to a large degree by age and concomitant diseases.
Similar articles
-
Prescriptions of recommended heart failure medications can be correlated with patient and physician characteristics.Int J Clin Pract. 2009 Feb;63(2):226-32. doi: 10.1111/j.1742-1241.2008.01937.x. Int J Clin Pract. 2009. PMID: 19196361
-
A survey of outpatient management of elderly heart failure patients in Poland-treatment patterns.Int J Cardiol. 2004 Jun;95(2-3):177-84. doi: 10.1016/j.ijcard.2003.04.027. Int J Cardiol. 2004. PMID: 15193817
-
Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study.Int J Cardiol. 2007 Jun 12;118(3):363-9. doi: 10.1016/j.ijcard.2006.07.033. Epub 2006 Oct 16. Int J Cardiol. 2007. PMID: 17049391
-
Management of cardiovascular conditions in Australian general practice.Aust Fam Physician. 2005 Jun;34(6):410-1. Aust Fam Physician. 2005. PMID: 15931397 Review.
-
Influence of sex on treatment and outcome in chronic heart failure.Cardiovasc Ther. 2012 Jun;30(3):182-92. doi: 10.1111/j.1755-5922.2010.00253.x. Epub 2011 Jan 31. Cardiovasc Ther. 2012. PMID: 21599874 Review.
Cited by
-
Non-employment and low educational level as risk factors for inequitable treatment and mortality in heart failure: a population-based cohort study of register data.BMC Public Health. 2021 Jun 2;21(1):1040. doi: 10.1186/s12889-021-10919-1. BMC Public Health. 2021. PMID: 34078322 Free PMC article.
-
Guideline adherence for pharmacotherapy of chronic systolic heart failure in general practice: a closer look on evidence-based therapy.Clin Res Cardiol. 2008 Apr;97(4):244-52. doi: 10.1007/s00392-007-0617-6. Epub 2007 Nov 28. Clin Res Cardiol. 2008. PMID: 18046524
-
Heart failure epidemiology and treatment in primary care: a retrospective cross-sectional study.ESC Heart Fail. 2021 Feb;8(1):489-497. doi: 10.1002/ehf2.13105. Epub 2020 Nov 7. ESC Heart Fail. 2021. PMID: 33159393 Free PMC article.
-
Design and methodology of the COACH-2 (Comparative study on guideline adherence and patient compliance in heart failure patients) study: HF clinics versus primary care in stable patients on optimal therapy.Neth Heart J. 2012 Aug;20(7-8):307-12. doi: 10.1007/s12471-012-0284-8. Neth Heart J. 2012. PMID: 22527916 Free PMC article.
-
Socio-economic inequalities and heart failure morbidity and mortality: A systematic review and data synthesis.ESC Heart Fail. 2025 Apr;12(2):927-941. doi: 10.1002/ehf2.14986. Epub 2024 Sep 25. ESC Heart Fail. 2025. PMID: 39318286 Free PMC article.
References
-
- Cleland JG, Cohen-Solal A, Aguilar JC, Dietz R, Eastaugh J, Follath F, Freemantle N, Gavazzi A, Van Gilst WH, Hobbs FD, Korewicki J, Madeira HC, Preda I, Swedberg K, Widimsky J. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet. 2002;360:1631–1639. doi: 10.1016/S0140-6736(02)11601-1. - DOI - PubMed
-
- Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20:248–254. - PubMed
-
- Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Jacobs AK, Hiratzka LF, Russell RO, Smith SC., Jr ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure) J Am Coll Cardiol. 2001;38:2101–2113. doi: 10.1016/S0735-1097(01)01683-7. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous